• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    Generics

    Strides Acquires Sandoz Generic Brands to Boost Africa Business

    PRESS RELEASE

    Strides and Incepta Partner to Expand Women’s Health Access

    PRESS RELEASE

    Strides Pharma gets USFDA approval for Celecoxib Capsules

    PRESS RELEASE

    Strides acquires identified ANDAs from Nostrum Laboratories

    PRESS RELEASE

    Strides gains FDA approval for Acetaminophen and Ibuprofen

    PRESS RELEASE

    Strides Pharma subsidiary receives USFDA approval for 60 mg Fluoxetine tablets

    EXPRESSPHARMA

    Strides gets USFDA nod for Theophylline extended-release tablets

    ECONOMICTIMES

    Strides receives USFDA approval for Sucralfate OralSuspension, 1gm/10 mL

    EXPRESS PHARMA

    Strides Pharma arm gets USFDA nod for generic Mycophenolate Mofetil oral sus

    ECONOMICTIMES

    Strides Pharma Arms Gets USFDA Approval For Potassium-Deficiency Drug

    ECONOMICTIMES

    Australian Competition Commission clears Arrow and Apotex merger: Strides

    ECONOMIC TIMES

    Jublia (efinaconazole) : Valeant Pharma, Dow Pharma, Kaken v. Strides Pharma

    PATENT LITIGATION

    Gilenya (Fingolimod): Novartis Pharmaceuticals Corporation v. Accord Healthcare Inc. et al

    PATENT LITIGATION

    Strides Shasun’s generic Ibuprofen receives USFDA approval

    BIOSPECTRUM

    Strides Shasun receives USFDA approval to market lipid lowering drug

    BUSINESS-STANDARD

    Strides Shasun buys Perrigo’s US FDA-approved API plant in India

    IN-PHARMATECHNOLOGIST

    Strides Arcolab to buy generic drugs business in Australia from Aspen Pharmacare

    THE ECONOMIC TIMES

    Cadila Healthcare to acquire Claris Lifesciences for Rs 3,400 crore

    THE ECONOMIC TIMES

    Strides Arcolab gets USFDA nod for bowel-cleansing medicine

    THE ECONOMIC TIMES

    Strides Arcolab Launches Generic Version Of Sofosbuvir

    THE ECONOMIC TIMES

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.